Skip to main content

Omnicell and Pandora merge, bolstering medication analytics

By Mike Miliard , Executive Editor

Omnicell, which makes automated dispensing systems and other medication management solutions for acute care facilities, announced Wednesday its acquisition of Pandora Data Systems, a Scotts Valley, Calif.-based provider of data analysis software for medication diversion detection.

Execs say the merger will make the most of both firms' expertise in medication analytics to improve clinical benchmarking that helps ensure regulatory compliance.

“We believe the two companies' complementary, best-in-class products and technologies will be of great value to all of our customers," said Jim Felich, CEO of Pandora Data Systems. "Our partnership with the Omnicell team will allow us to continue our commitment to patient safety and help hospital systems meet the increasingly stringent requirements of the DEA and The Joint Commission."

The Pandora Data Systems solution will continue to operate as a stand-alone product, producing reports for CareFusion, McKesson, Cerner and other medication management systems, and providing regular updates and releases for its customer base.

Meanwhile, the company will leverage Omnicell's development expertise to provide best-in-class analytics for drug diversion detection, compliance reporting and long term data storage. Pandora's customers will also benefit from Omnicell's infrastructure for expanded service and support.

"I am thrilled to welcome the Pandora employees and customers to the Omnicell family, as together, we commit to the universal improvement of healthcare," said Randall Lipps, CEO of Omnicell. "Pandora's analytic expertise will allow us to further enhance hospital medication management, providing valuable information to pharmacy and nursing management while reducing the frequency of drug diversions. Most importantly, the companies share a common vision to improve healthcare for everyone, and we believe our combined technology will be able to increase hospital patient safety and augment their ability to meet regulatory compliance."